{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:05:32Z","timestamp":1789185932820,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejso.2026.111770","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:01:06Z","timestamp":1774486866000},"page":"111770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests"],"prefix":"10.1016","volume":"52","author":[{"given":"A.","family":"Marichez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.T.","family":"Passand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-6369","authenticated-orcid":false,"given":"M.","family":"Boubaddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-8479","authenticated-orcid":false,"given":"B.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-6349","authenticated-orcid":false,"given":"C.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saltel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111770_bib1","article-title":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Heal - Eur"},{"key":"10.1016\/j.ejso.2026.111770_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical presentation, diagnosis and staging of cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ejso.2026.111770_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajpath.2024.06.013","article-title":"The search for risk, diagnostic, and prognostic biomarkers of cholangiocarcinoma and their biological and clinicopathologic significance","volume":"195","author":"Macias","year":"2025","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2023.01.027","article-title":"Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma","volume":"78","author":"Cadamuro","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.gie.2016.03.789","article-title":"Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video)","volume":"84","author":"Navaneethan","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejso.2026.111770_bib7","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/bjs.6057","article-title":"Immunoglobulin G4\u2010related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures","volume":"95","author":"Erdogan","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.111770_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrad104","article-title":"Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study","volume":"7","author":"Byrling","year":"2023","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2026.111770_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","article-title":"Cholangiocarcinoma 2026: status quo, unmet needs and priorities","volume":"23","author":"Banales","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"Javle","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhep.2025.03.007","article-title":"EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma","volume":"83","author":"Marzioni","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000360791","article-title":"Current diagnostic and management options in perihilar cholangiocarcinoma","volume":"89","author":"Rizvi","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.ejso.2026.111770_bib14","first-page":"1","article-title":"Blurring the anatomical lines in extrahepatic cholangiocarcinoma: an integrated clinic-oncological and exploratory proteomic comparison of perihilar and distal tumors","author":"Marichez","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib16","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1245\/s10434-024-14939-0","article-title":"Revisiting the malignant masquerade at the liver hilum: have we made progress?","volume":"31","author":"Jain","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/bjs.11257","article-title":"Benign hilar bile duct strictures resected as perihilar cholangiocarcinoma","volume":"106","author":"Otsuka","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.111770_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.surg.2013.12.032","article-title":"When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery","volume":"155","author":"Asbun","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2026.111770_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","volume":"95","author":"Patel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111770_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000098014","article-title":"Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis","volume":"23","author":"John","year":"2007","journal-title":"Dig Surg"},{"key":"10.1016\/j.ejso.2026.111770_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrab127","article-title":"Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer","volume":"5","author":"Kim","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2026.111770_bib22","first-page":"5501","article-title":"Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer","volume":"47","author":"Tempero","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2026.111770_bib23","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic accuracy of Serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit : Int Med J Exp Clin Res"},{"key":"10.1016\/j.ejso.2026.111770_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2018.02.008","article-title":"The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma","volume":"480","author":"Qiu","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejso.2026.111770_bib25","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3748\/wjg.v16.i37.4697","article-title":"Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma","volume":"16","author":"Leelawat","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111770_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/sjg.SJG_447_19","article-title":"Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma","volume":"26","author":"Wang","year":"2020","journal-title":"Saudi J Gastroenterol : Off J Saudi Gastroenterol Assoc"},{"key":"10.1016\/j.ejso.2026.111770_bib27","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200212","article-title":"The role of resolvin D1 in the differential diagnosis of the cholangiocarcinoma and benign biliary diseases","volume":"66","author":"G\u00fcl-Utku","year":"2020","journal-title":"Clin Lab"},{"key":"10.1016\/j.ejso.2026.111770_bib28","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/873548","article-title":"Serum NGAL to clinically distinguish cholangiocarcinoma from benign biliary tract diseases","volume":"2011","author":"Leelawat","year":"2011","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.32074\/1591-951X-251","article-title":"Benign biliary neoplasms and biliary tumor precursors","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/j.ejso.2026.111770_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.humpath.2022.06.012","article-title":"Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges","volume":"132","author":"Liu","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.humpath.2010.01.014","article-title":"S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy","volume":"41","author":"Levy","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib32","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.humpath.2015.07.005","article-title":"Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy","volume":"46","author":"Chen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MCG.0000000000001118","article-title":"The diagnostic yield of malignancy comparing cytology, FISH, and molecular analysis of cell free cytology brush supernatant in patients with biliary strictures undergoing Endoscopic Retrograde Cholangiography (ERC)","volume":"53","author":"Kushnir","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111770_bib34","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/j.gastro.2009.02.040","article-title":"A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures","volume":"136","author":"Fritcher","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2026.111770_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jasc.2024.03.002","article-title":"Performance of fluorescence in situ hybridization in biliary brushings with equivocal cytology: an institutional experience","volume":"13","author":"Miller","year":"2024","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.ejso.2026.111770_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-018-4906-x","article-title":"Role of fluorescent in situ hybridization, cholangioscopic biopsies, and EUS-FNA in the evaluation of biliary strictures","volume":"63","author":"Brooks","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib37","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in Situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2026.111770_bib38","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.3390\/jcm13216457","article-title":"Diagnostic accuracy performance of Fluorescence In Situ Hybridization (FISH) for biliary strictures: a systematic review and meta-analysis","volume":"13","author":"Aggarwal","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejso.2026.111770_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.humpath.2020.04.002","article-title":"DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies","volume":"99","author":"Lee","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ajcp\/aqab130","article-title":"Role of DNA flow cytometry in the diagnosis of malignancy in bile duct biopsies using paraffin-embedded tissue","volume":"157","author":"Wu","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib41","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1007\/s10620-021-07138-4","article-title":"Brush cytology, Forceps Biopsy, or endoscopic ultrasound-guided sampling for diagnosis of bile duct cancer: a meta-analysis","volume":"67","author":"Yoon","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5009\/gnl13292","article-title":"Triple-Tissue sampling during Endoscopic Retrograde Cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejso.2026.111770_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.gie.2015.09.024","article-title":"Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis","volume":"83","author":"Sadeghi","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejso.2026.111770_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ajg.2014.363","article-title":"Awareness of tract seeding with Endoscopic ultrasound tissue acquisition in perihilar cholangiocarcinoma","volume":"110","author":"Razumilava","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111770_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000504910","article-title":"Role of peroral cholangioscopy for diagnosis and staging of biliary tumors","volume":"38","author":"Pereira","year":"2020","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejso.2026.111770_bib46","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1055\/s-0042-100194","article-title":"The efficacy of peroral cholangioscopy for difficult bile duct stones and indeterminate strictures: a systematic review and meta-analysis","volume":"4","author":"Korrapati","year":"2016","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.ejso.2026.111770_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","article-title":"Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures","volume":"69","author":"Singhi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2026.111770_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gie.2024.12.024","article-title":"Next-generation sequencing improves the detection of malignant biliary strictures and changes management","volume":"102","author":"Bardhi","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejso.2026.111770_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41424-018-0015-6","article-title":"Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma","volume":"9","author":"Bankov","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.ejso.2026.111770_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jmoldx.2015.08.002","article-title":"Next-Generation sequencing and fluorescence in Situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy","volume":"18","author":"Dudley","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ejso.2026.111770_bib51","first-page":"a26873552","article-title":"Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures","volume":"13","author":"Meijering","year":"2025","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.ejso.2026.111770_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/HEP.0000000000000970","article-title":"Utility of methylated DNA markers for the diagnosis of malignant biliary strictures","volume":"81","author":"Cooley","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.gie.2021.07.005","article-title":"Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology","volume":"95","author":"Prachayakul","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejso.2026.111770_bib54","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/hep4.1730","article-title":"DNA methylation markers for detection of cholangiocarcinoma: discovery, validation, and clinical testing in biliary brushings and plasma","volume":"5","author":"Yang","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ejso.2026.111770_bib55","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41416-022-01738-1","article-title":"HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples","volume":"126","author":"Loi","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.111770_bib56","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.27707","article-title":"Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma","volume":"61","author":"Andresen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib57","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.3390\/ijms25116002","article-title":"The diagnostic and prognostic potentials of non-coding RNA in cholangiocarcinoma","volume":"25","author":"Andrade","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/hep.22838","article-title":"MicroRNA\u201021 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3","volume":"49","author":"Selaru","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib59","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jhep.2011.10.022","article-title":"Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma","volume":"56","author":"Chapman","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib60","first-page":"683","article-title":"Mass spectrometry\u2010based proteomic analysis of formalin\u2010fixed paraffin\u2010embedded extrahepatic cholangiocarcinoma","volume":"22","author":"Maeda","year":"2015","journal-title":"J Hepato-Bil-Pan Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/diagnostics11060999","article-title":"Diagnostic and prognostic value of circulating cell-free DNA for cholangiocarcinoma","volume":"11","author":"Wintachai","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejso.2026.111770_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-019-0634-0","article-title":"Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases","volume":"11","author":"Wasenang","year":"2019","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejso.2026.111770_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-024-03067-y","article-title":"Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics","volume":"43","author":"Shi","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111770_bib64","article-title":"Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma","author":"Yoo","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib65","article-title":"Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer","author":"Hwang","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib66","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.3390\/jcm13206177","article-title":"Circulating miR-18a and miR-532 levels in extrahepatic cholangiocarcinoma","volume":"13","author":"Orzan","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejso.2026.111770_bib67","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/cas.12300","article-title":"Plasma miR\u201021 is a novel diagnostic biomarker for biliary tract cancer","volume":"104","author":"Kishimoto","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in serum and bile of patients with primary sclerosing Cholangitis and\/or Cholangiocarcinoma","volume":"10","author":"Voigtl\u00e4nder","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2026.111770_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023584","article-title":"Real-Time PCR-Based analysis of the human bile MicroRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer","volume":"6","author":"Shigehara","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2026.111770_bib70","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/CMAR.S158155","article-title":"Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2026.111770_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12967-022-03294-x","article-title":"Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives","volume":"20","author":"Zhao","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejso.2026.111770_bib72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cells9030721","article-title":"Patients with Cholangiocarcinoma present specific RNA profiles in serum and urine extracellular vesicles mirroring the tumor expression: novel liquid biopsy biomarkers for disease diagnosis","volume":"9","author":"Lapitz","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejso.2026.111770_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/105358","article-title":"Novel serum biomarkers to differentiate cholangiocarcinoma from benign biliary tract diseases using a proteomic approach","volume":"2015","author":"Janvilisri","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejso.2026.111770_bib74","article-title":"Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer","volume":"5","author":"Christensen","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejso.2026.111770_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111770_bib76","article-title":"Exosomal Cripto-1 serves as a potential biomarker for perihilar cholangiocarcinoma","volume":"11","author":"Hu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib77","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29291","article-title":"Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"66","author":"Arbelaiz","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib78","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.3390\/molecules27185904","article-title":"Translational proteomic approach for Cholangiocarcinoma Biomarker Discovery, validation, and Multiplex Assay development: a pilot Study","volume":"27","author":"Watcharatanyatip","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejso.2026.111770_bib79","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/acs.jproteome.2c00846","article-title":"Accurate discrimination of benign biliary diseases and cholangiocarcinoma with Serum multiomics revealed by high-throughput nanoassisted laser desorption ionization Mass spectrometry","volume":"22","author":"Qu","year":"2023","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ejso.2026.111770_bib80","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/cancers12061433","article-title":"A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma","volume":"12","author":"Macias","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111770_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","volume":"205","author":"Zhang","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ejso.2026.111770_bib82","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/cancers12061644","article-title":"Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach","volume":"12","author":"Urman","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111770_bib83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1245\/s10434-015-4878-4","article-title":"Verification of WFA-Sialylated MUC1 as a sensitive biliary biomarker for human biliary tract cancer","volume":"23","author":"Yamaguchi","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib84","first-page":"699","article-title":"Detection of early-stage extrahepatic cholangiocarcinoma in patients with biliary strictures by soluble B7-H4 in the bile","volume":"8","author":"Ke","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ejso.2026.111770_bib85","article-title":"Application of CAPTURE assay for early diagnosis and prognosis in bile and blood of cholangiocarcinoma","volume":"9","author":"Tsai","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib86","article-title":"Bile is a reliable and valuable source to study cfDNA in biliary tract cancers","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111770_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100275","article-title":"Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer","volume":"6","author":"Gou","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejso.2026.111770_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/cancers13010039","article-title":"Bile-Based cell-free DNA analysis is a reliable diagnostic tool in pancreatobiliary cancer","volume":"13","author":"Driescher","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111770_bib89","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1111\/cas.16365","article-title":"Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers","volume":"115","author":"Ito","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110916","article-title":"Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma","volume":"116","author":"Yin","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.ejso.2026.111770_bib91","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/diagnostics12112704","article-title":"Genetic analyses of cell-free DNA in pancreatic juice or bile for diagnosing pancreatic duct and biliary tract strictures","volume":"12","author":"Nagai","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejso.2026.111770_bib92","article-title":"Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures","author":"Arechederra","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2026.111770_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101736","article-title":"Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples","volume":"55","author":"He","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejso.2026.111770_bib94","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1021\/acs.analchem.4c03462","article-title":"Liquid biopsy-based accurate diagnosis and genomic profiling of hard-to-biopsy tumors via parallel single-cell genomic sequencing of exfoliated tumor cells","volume":"96","author":"Zhang","year":"2024","journal-title":"Anal Chem"},{"key":"10.1016\/j.ejso.2026.111770_bib95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","article-title":"Bile-Based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity","volume":"14","author":"Shin","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ejso.2026.111770_bib96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ajcp\/aqac015","article-title":"Analysis of MicroRNA in bile cytologic samples is useful for detection and diagnosis of extrahepatic cholangiocarcinoma","volume":"158","author":"Uchihata","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejso.2026.111770_bib97","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human bile contains MicroRNA\u2010laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cas.15597","article-title":"Clinical impact of bile\u2010derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers","volume":"114","author":"Yoshida","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hbpd.2019.10.009","article-title":"Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma","volume":"19","author":"Han","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ejso.2026.111770_bib100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib101","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/2050640616687836","article-title":"A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin","volume":"5","author":"Voigtlander","year":"2016","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.ejso.2026.111770_bib102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12916-023-02990-9","article-title":"Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma","volume":"21","author":"Gao","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.ejso.2026.111770_bib103","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.7150\/jca.40964","article-title":"Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients","volume":"11","author":"Son","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.ejso.2026.111770_bib104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cts.12890","article-title":"Liquid biopsy of bile based on targeted mass spectrometry for the diagnosis of malignant biliary strictures","volume":"14","author":"Adrait","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","article-title":"Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma","volume":"27","author":"Voigtl\u00e4nder","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ejso.2026.111770_bib106","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/HEP.0000000000000957","article-title":"Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases","volume":"81","author":"Yang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111770_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221024","article-title":"Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis","volume":"14","author":"Duangkumpha","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2026.111770_bib108","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326003896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326003896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:06:04Z","timestamp":1789182364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326003896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0748798326003896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111770","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extra-hepatic cholangiocarcinoma diagnosis: from classical pathological analysis to the emerging omics tests","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111770"}}